KPV Peptide For Sale
Buy KPV peptide: 10mg listed purchase quantities. Compare live prices across 10 listed vendors with real cost per mg, recorded COA availability and discount codes.
Buy KPV peptide starting at $25.00/purchase from 10 listed vendors. Compare 10mg purchase quantity options by cost per mg, price per purchase, monthly cost, discount codes and recorded COA metadata (not independent verification).
How much does KPV cost per month?
An illustrative KPV cost model works out to about $37.89 per month: Ascension Peptides's listed 10 mg purchase quantity at $25.00 with code WPA, divided into 0.5 mg amounts daily. This quantity provides 20.0 nominal portions — about 2.9 weeks at the selected cadence, before preparation losses or stability limits — for roughly $8.75 per week or $37.89 per 4.33-week month. Vial count and milligrams per vial must be checked separately. This is illustrative arithmetic combining independently selected lifetime modal inputs, not a verified most-common joint protocol. The amount distribution includes 7,833 calculator runs; overall cadence comes from 1,957 separate lifetime frequency responses across amounts. Calculator inputs are not confirmed administration or recommendations.
Use the live cost-per-month card to change nominal purchase quantity, amount, cadence and vendor strategy. Recorded purity can be compared separately; it is not independent verification or a quality guarantee. Confirm package composition and checkout price with the vendor.
About KPV
Pre-clinical / research-onlyAlso known as: Lysine-Proline-Valine · α-MSH(11-13)KPV is an anti-inflammatory research peptide most often sourced for gut and skin protocols, frequently paired with BPC-157. It ships as a lyophilized powder you reconstitute with bacteriostatic water (and is sometimes used in oral or topical form).[1]
What to check before you buy KPV:
- A third-party COA with mass-spec confirmation of the Lys-Pro-Val identity and mass, plus purity by HPLC — not just an in-house "tested" stamp.
- A COA dated within the last 6–12 months that matches the exact vial size and batch you are buying.
- Accurate vial fill: a 10mg label should assay close to 10mg. Under-filled or mislabeled vials are a common failure mode, and they throw off every reconstitution calculation.
Pre-clinical work has focused on inflammatory bowel disease — orally and rectally administered KPV reduced colitis severity in DSS and TNBS mouse models and ex-vivo human colonic biopsies — and on atopic dermatitis and psoriasiform skin inflammation.[3] No randomized human trials have been published; clinical interest persists in IBD adjuvant therapy and topical dermatology formulations.
Regulatory: Not FDA-approved for any indication. Sold as a research peptide and as a cosmetic ingredient in some topical formulations.
KPV: Mechanisms, Half-Life & Research Data
A skimmable deep dive into how KPV works and what it is being studied for — tied back to what size to buy. Detailed debates and community notes are tucked into the expandable panels below. All citations resolve to the sources list at the bottom of this page.
How it works
KPV is the C-terminal three-amino-acid fragment (Lysine-Proline-Valine) of α-melanocyte-stimulating hormone (α-MSH). Despite being a peptide, it is small and lipophilic enough to diffuse passively across cell membranes and act intracellularly – unusual for a peptide, which normally must bind a surface receptor to signal.[1][2] Once inside the cell, KPV inhibits nuclear translocation of NF-κB, the master transcription factor that drives pro-inflammatory cytokine production (tumor necrosis factor α, interleukin-6, interleukin-8).[2][6] KPV retains its anti-inflammatory effect in MC1R-knockout models, meaning it does not depend on the melanocortin-receptor binding that the parent α-MSH peptide uses.[2] A second uptake route was characterised by Dalmasso and colleagues: the di/tripeptide transporter PepT1, which is over-expressed on inflamed colonic epithelium, actively pulls KPV into intestinal cells and concentrates it at the site of inflammation.[5] KPV is also more stable to gastric proteases than most peptides of its class, which is why oral and rectal formulations are the most-studied routes in the published literature.
Active research areas
- Inflammatory bowel disease (pre-clinical)The largest body of work. Orally and rectally administered KPV reduced colitis severity in dextran sulfate sodium (DSS) and trinitrobenzenesulfonic acid (TNBS) mouse models and in ex-vivo human colonic biopsies, with the PepT1 uptake route shown to concentrate KPV in inflamed mucosa.[3][5] No randomised human trial has been published.
- Targeted-delivery nanoparticle formulationsLaroui and colleagues developed CD98-siRNA/KPV-loaded polymer nanoparticles designed to concentrate KPV in inflamed colonic tissue – an active translational direction aimed at converting the pre-clinical signal into a deliverable IBD therapeutic.[7]
- Atopic dermatitis and psoriasiform skin inflammationReviews from the Luger and Brzoska groups describe KPV and related α-MSH C-terminal tripeptides as candidate topical agents for atopic dermatitis, psoriasis, and contact dermatitis on the basis of NF-κB inhibition in keratinocytes and skin-resident immune cells.[4][6] No Phase 2 trial has been published.
- Mast-cell-mediated allergic inflammationMechanistic work has reported that α-MSH C-terminal fragments suppress mast-cell degranulation and IgE-mediated activation in vitro,[4] generating interest in KPV for chronic urticaria and allergic skin disease. Pre-clinical only at present.
- Mucositis and other epithelial inflammation
Open questions & leading hypotheses (2)
- Hypothesis: Oral KPV at typical research-grade doses (200–500 µg) reaches clinically meaningful intracellular concentrations in human inflamed bowel.Evidence: PepT1 over-expression on inflamed colonic epithelium provides a plausible concentration mechanism,[5] and the murine colitis efficacy data are reproducible across multiple labs.[3][7] Counter-evidence: no published human pharmacokinetic study has measured intra-mucosal KPV concentrations after oral dosing, and the murine doses (mg/kg range) far exceed the µg-per-dose protocols in widespread research use; whether human exposure crosses a therapeutic threshold is genuinely unknown.
- Hypothesis: KPV is meaningfully better-targeted to the bowel than systemic α-MSH or oral corticosteroids, which would justify preferential development for IBD.Evidence: Pre-clinical comparisons show KPV concentrates in inflamed colonic tissue via PepT1 and lacks the pigmentary, appetite, and HPA-axis effects of the parent α-MSH molecule.[2][5] Counter-evidence: the absence of a registered randomised human IBD trial 15+ years after the original colitis papers is itself evidence that translation has been harder than the pre-clinical work implied – manufacturing economics, regulatory positioning, or efficacy that did not survive scale-up are all plausible explanations.
What community users report
Anecdotal — not controlled-trial evidence
Across r/Peptides, r/UlcerativeColitis, and r/CrohnsDisease, users most frequently report taking KPV orally (often in capsule form, 200–500 µg, once or twice daily) and pairing it with BPC-157 as a "gut healing" stack for ulcerative colitis, Crohn's disease, IBS, and post-antibiotic dysbiosis.[8][9] Reported effects include reduced stool urgency, less visible blood, lower symptom-flare frequency, and reduced skin reactivity in users with co-existing atopic disease. Side effects are infrequently reported – mild headache and occasional GI bloating are the most common. **These reports are anecdotal and have not been validated in controlled trials.** They are useful for understanding which protocols people are running, but they do not establish that KPV is safe or effective for IBD, dermatitis, or any other inflammatory condition.
Sources & references (9)
Peer-reviewed literature, FDA documents, and trial registrations cited above. Vendor pricing, COA data, and live calculator statistics shown elsewhere on this page are sourced from the WPA database independently of this list.
- [1]Hiltz ME, Lipton JM. Antiinflammatory activity of a COOH-terminal fragment of the neuropeptide alpha-MSH. FASEB J 1989;3:2282–2284. · PMID: 2792441 link
- [2]Mandrika I et al. Effects of melanocortin peptides on lipopolysaccharide / interferon-γ-induced NF-κB activation. Biochem Pharmacol 2001;61:613–621. · PMID: 11239505 link
- [3]Kannengiesser K et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis 2008;14:324–331. · PMID: 18092346 link
- [4]Brzoska T et al. α-Melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev 2008;29:581–602. · PMID: 18612139 link
- [5]Dalmasso G et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology 2008;134:166–178. · PMID: 18061177 link
- [6]Luger TA, Brzoska T. α-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs. Ann Rheum Dis 2007;66 Suppl 3:iii52–iii55. · PMID: 17934097 link
- [7]Laroui H et al. Targeting intestinal inflammation with CD98 siRNA/KPV-loaded nanoparticles (Laroui, Mol Ther / Gastroenterology-class work). link
- [8]Community report – r/Peptides KPV and BPC-157 gut-stack threads (subreddit), accessed May 2026. link
- [9]Community report – r/UlcerativeColitis and r/CrohnsDisease KPV experience threads (subreddit), accessed May 2026. link
What KPV Costs Right Now
WPA currently tracks KPV from 10 distinct vendors. In-stock KPV vials run from $25 to $59.76 — a 2.4x spread for the same compound. Ascension Peptides holds the lowest sticker price at $25. Normalized to milligrams, KPV costs $2.50/mg to $5.98/mg on this page. The best per-milligram value is the listed 10 mg purchase quantity from Ascension Peptides.
KPV is stocked in a single size: 10 mg listed quantity; vial count not recorded. Because vials of different strengths rarely scale linearly in price, the per-milligram column is the only fair way to rank them.
Ranked by true cost per milligram, the KPV listings WPA tracks are: Ascension Peptides — 10mg at $25 ($2.50/mg), COA purity 99.94%; Southern Aminos — 10mg at $33.15 ($3.31/mg), COA purity 99.79%; Modified Aminos — 10mg at $34.19 ($3.42/mg), COA purity 99.00%; EZ Peptides — 10mg at $39.60 ($3.96/mg), COA purity 99.18%; Ameano Peptides — 10mg at $39.60 ($3.96/mg).
KPV COA Coverage Across Tracked Vendors
9 of the 10 tracked KPV listings (90%) are marked as having COA availability in WPA's listing data; this marker is not independent verification. A purity value is recorded for 9 listings; purity alone does not establish identity or independent testing. The recorded purity values range from 99.00% to 99.94%. 8 listings record more KPV in the vial than the label claims; check the vendor's report and batch before drawing conclusions. The latest COA date recorded in WPA's listing data is 9/26.
To assess a COA, inspect the actual report for the independent lab, test date, and a batch and vial size matching the KPV offer. WPA's listing fields do not establish that a report was independently verified.
KPV Calculator Input Observations
In lifetime KPV calculator inputs, 500mcg is the most frequent entered amount (2,209 of 7,833 runs). Separately, Daily (7x/wk) is the most frequent overall cadence (672 of 1,957 lifetime frequency responses, across entered amounts). Among lifetime frequency responses with amounts within ±8% of 500mcg, Daily (7x/wk) is most frequent (234 of 656 responses). Calculator runs and frequency responses are different populations, not unique people or confirmed administration. Separate modal inputs do not establish a most-common joint protocol, a recommendation, or a cycle length. As nominal quantity arithmetic only, 10 mg of listed product divided by 0.5 mg gives roughly 20 portions before preparation losses. This does not establish vial count, stability after preparation, or cycle length.
KPV Discount Codes
10 of the 10 tracked KPV listings carry a WPA researcher discount code. The largest live discount is 50% off. Every price and per-milligram figure on this page is the post-discount number, so you are never comparing a discounted listing against an undiscounted one. Codes change and some exclude sale items or carry order minimums.
About KPV
KPV is an anti-inflammatory research peptide most often sourced for gut and skin protocols, frequently paired with BPC-157. It ships as a lyophilized powder you reconstitute with bacteriostatic water (and is sometimes used in oral or topical form).
KPV is tracked under the Skin Peptides category on WPA. Its reported half-life is ~1 hour. Calculator inputs do not establish why a cadence was selected or validate a protocol. Not FDA-approved for any indication.
How to Read the KPV Comparison
- Price per milligram — Every KPV listing is normalized to $2.50/mg-style unit pricing, so a small cheap vial cannot hide a worse real cost than a larger one.
- COA metadata and purity — 9 KPV listings are marked for COA availability, and 9 have a recorded purity value. These fields do not independently verify a report.
- Stock status — Live in-stock state for each KPV listing, refreshed on a recurring basis.
Frequently Asked Questions: KPV
Is it legal and safe to buy KPV for research?
In the US, KPV is sold strictly as a research chemical — legal to buy for laboratory research but not approved for human use. KPV is a short fragment of alpha-MSH with no approved human form, sold for laboratory use only. The real variable isn't legality, it's quality: unverified suppliers can ship underdosed, impure, or mislabeled material. WPA records COA-related listing fields where supplied, but does not independently verify every report. Inspect the actual batch report and its laboratory, identity testing, and date before drawing conclusions. Right now that screen covers 10 KPV listings from 10 vendors.
How do I verify a KPV COA so I'm not getting an underdosed vial?
A Certificate of Analysis (COA) may report tests for a specific KPV batch. Check that the report identifies the compound (actually KPV, not a longer MSH fragment or an underdosed substitute), names the laboratory, describes the test method and result, and matches the offered batch and date. A recorded purity value or COA-availability flag in WPA's listing data is not independent verification. Open the vendor listing and inspect the actual report before drawing conclusions. For KPV specifically, 9 of 10 tracked listings (90%) are marked as having COA availability in WPA's listing data; that marker is not independent verification. A purity value is separately recorded for 9 listings; purity alone does not establish identity or independent testing. The latest COA date recorded in the listing data is 9/26.
Which KPV vendor should I pick?
There's no single "best" KPV vendor — it depends on what you weigh most. WPA ranks tracked listings using recorded purity and date fields where available, visitor click activity, price, stock status, and discount data; this ranking is not independent verification of a report. 10 vendors currently carry KPV, and Ascension Peptides holds the best true value at $2.50/mg on the 10 mg listed purchase quantity. Review the actual report and confirm its batch details before making a decision.
How much does KPV cost — and how do I know I'm not overpaying?
Judge KPV by true price per milligram, not the sticker price on one vial — a cheap small vial often costs more per mg than a larger one. It most often ships in 10 mg vials, so compare $/mg across those before assuming the cheapest vial wins. Tracked KPV listings currently run $2.50/mg to $5.98/mg across 10mg listed purchase quantities (not necessarily single vials). WPA normalizes tracked listings to $/mg, and the live cost-per-month card estimates your spend at the most common dose. The one catch: the lowest $/mg sometimes means buying a bigger vial than your cycle needs.
How much KPV do I need for one full cycle?
In lifetime KPV calculator inputs, 500mcg is the most frequent entered amount (2,209 of 7,833 runs). Separately, Daily (7x/wk) is the most frequent overall cadence (672 of 1,957 lifetime frequency responses, across entered amounts). Among lifetime frequency responses with amounts within ±8% of 500mcg, Daily (7x/wk) is most frequent (234 of 656 responses). Calculator runs and frequency responses are different populations, not unique people or confirmed administration. Separate modal inputs do not establish a most-common joint protocol, a recommendation, or a cycle length. Dividing the listed 10 mg purchase quantity by 0.5 mg gives roughly 20 nominal portions before preparation losses; vial count and stability after preparation are separate questions. A cycle requires an independently chosen amount, cadence and time horizon; calculator observations do not supply those decisions. Compare nominal package quantities and model your own selections in the cost card.
Are discount codes available for KPV?
Participating KPV vendors may offer WPA researcher discount codes. Codes can change, exclude sale items or carry order minimums. 10 of the 10 tracked KPV listings carry a code right now, the largest worth 50% off. Each listing shows the recorded code and discounted price where available; confirm the actual package and checkout terms with the vendor.
Where can I compare KPV prices and listing details?
This comparison shows 10 tracked listings for KPV in the selected format. Compare purchase price, established nominal quantities, discount terms and recorded COA availability, purity and date fields. Those fields are not independent verification. Inspect actual batch reports and confirm package composition and checkout price on the vendor's site.